The present invention encompasses compounds of formula (I) wherein the groups R1 to R7, A, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.本發明涵蓋式(I)化合物其中基團R1至R7、A、V、W、X、Y、n、r及q如技術方案1中所定義;其作為MDM2-p53相互作用抑制劑之用途;含有此類化合物之醫藥組合物;其作為藥劑、尤其作為用於治療及/或預防致癌疾病之藥劑的用途;及合成中間物。